Consoli, A., Nurjhan, N., Capani, F. & Gerich, J. Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM. Diabetes 38, 550–557 (1989).
Magnusson, I., Rothman, D. L., Katz, L. D., Shulman, R. G. & Shulman, G. I. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. Journal of Clinical Investigation 90, 1323–1327 (1992).
Zoungas, S. et al. Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes. N. Engl. J. Med. 371, 1392–1406 (2014).
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R. & Neil, H. A. W. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359, 1577–1589 (2008).
Owen, O. E., Felig, P., Morgan, A. P., Wahren, J. & Cahill, G. F. Liver and kidney metabolism during prolonged starvation. J. Clin. Invest. 48, 574–583 (1969).
Joseph, S. E. et al. Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes 49, 450–456 (2000).
Meyer, C. et al. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J. Clin. Invest. 102, 619–624 (1998).
Gerich, J. E., Meyer, C., Woerle, H. J. & Stumvoll, M. Renal gluconeogenesis – Its importance in human glucose homeostasis. Diabetes Care 24, 382–391 (2001).
Lemieux, G., Aranda, M. R., Fournel, P. & Lemieux, C. Renal enzymes during experimental diabetes mellitus in the rat. Role of insulin, carbohydrate metabolism, and ketoacidosis. Can. J. Physiol. Pharmacol. 62, 70–75 (1984).
Weber, G., Lea, M. A., Convery, H. J. & Stamm, N. B. Regulation of gluconeogenesis and glycolysis: studies of mechanisms controlling enzyme activity. Adv. Enzyme Regul. 5, 257–300 (1967).
Mithieux, G. et al. Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes 45, 891–896 (1996).
Brown, M. S. & Goldstein, J. L. Selective versus Total Insulin Resistance: A Pathogenic Paradox. Cell Metab. 7, 95–96 (2008).
Li, S., Brown, M. S. & Goldstein, J. L. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. USA 107, 3441–3446 (2010).
Ferre, P. & Foufelle, F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP‐1c. Diabetes, Obesity and Metabolism 12, 83–92 (2010).
Reaven, G. M. Relationships Among Insulin Resistance, Type 2 Diabetes, Essential Hypertension, and Cardiovascular Disease: Similarities and Differences. J Clin Hypertens (Greenwich) 13, 238–243 (2011).
Rocchini, A. P. et al. Insulin and renal sodium retention in obese adolescents. Hypertension 14, 367–374 (1989).
Peterson, R. G., Shaw, W. N., Neel, M.-A., Little, L. A. & Eichberg, J. Zucker Diabetic Fatty Rat as a Model for Non-insulin-dependent Diabetes Mellitus. ILAR J 32, 16–19 (1990).
Etgen, G. J. & Oldham, B. A. Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state. Metabolism 49, 684–688 (2000).
Kurtz, T. W., Morris, R. C. & Pershadsingh, H. A. The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 13, 896–901 (1989).
Fujimoto, Y., Torres, T. P., Donahue, E. P. & Shiota, M. Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats. Diabetes 55, 2479–2490 (2006).
Lee, W. N. P., Bassilian, S., Lim, S. & Boros, L. G. Loss of regulation of lipogenesis in the Zucker diabetic (ZDF) rat. Am. J. Physiol. Endocrinol. Metab. 279, E425–E432 (2000).
Bassilian, S. et al. Loss of regulation of lipogenesis in the Zucker diabetic rat. II. Changes in stearate and oleate synthesis. Am. J. Physiol. Endocrinol. Metab. 282, E507–E513 (2002).
Resch, M. et al. Hyperaldosteronism and altered expression of an SGK1-dependent sodium transporter in ZDF rats leads to salt dependence of blood pressure. Hypertens. Res. 33, 1082–1088 (2010).
Large, V. & Beylot, M. Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin. Diabetes 48, 1251–1257 (1999).
Shimomura, I. et al. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. PNAS 96, 13656–13661 (1999).
Tatchum-Talom, R., Gopalakrishnan, V. & McNeill, J. R. Radiotelemetric monitoring of blood pressure and mesenteric arterial bed responsiveness in rats with streptozotocin-induced diabetes. Can. J. Physiol. Pharmacol. 78, 721–728 (2000).
Hartmann, J. F., Chen, S. L., Szemplinski, M. & Slater, E. E. Effect of insulin pump therapy on blood pressure and the renin-angiotensin system of diabetic rats. Horm. Metab. Res. 22, 141–144 (1990).
Ardenkjaer-Larsen, J. H. et al. Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc. Natl. Acad. Sci. USA 100, 10158–10163 (2003).
Golman, K., Zandt, R. I., Lerche, M., Pehrson, R. & Ardenkjaer-Larsen, J. H. Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Res. 66, 10855–10860 (2006).
Nelson, S. J. et al. Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-C-13]Pyruvate. Sci Transl Med 5, (2013).
Cunningham, C. H. et al. Hyperpolarized 13C Metabolic MRI of the HumanHeart: Initial Experience. Circ. Res. CIRCRESAHA. 116, 309769, https://doi.org/10.1161/CIRCRESAHA.116.309769 (2016).
Laustsen, C. et al. Assessment of early diabetic renal changes with hyperpolarized [1‐13C]pyruvate. Diabetes/Metabolism Research and Reviews 29, 125–129 (2013).
Lee, P. et al. In Vivo hyperpolarized carbon‐13 magnetic resonance spectroscopy reveals increased pyruvate carboxylase flux in an insulin‐resistant mouse model. Hepatology 57, 515–524 (2013).
Keshari, K. R. et al. Noninvasive In Vivo Imaging of Diabetes-Induced Renal Oxidative Stress and Response to Therapy Using Hyperpolarized 13C Dehydroascorbate Magnetic Resonance. Diabetes 64, 344–352 (2015).
Schroeder, M. A. et al. In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance. Proc. Natl. Acad. Sci. USA 105, 12051–12056 (2008).
von Morze, C. et al. Detection of localized changes in the metabolism of hyperpolarized gluconeogenic precursors (13) C-lactate and (13) C-pyruvate in kidney and liver. Magn Reson Med. https://doi.org/10.1002/mrm.26245 (2016).
Williamson, D. H., Lund, P. & Krebs, H. A. Redox State of Free Nicotinamide-Adenine Dinucleotide in Cytoplasm and Mitochondria of Rat Liver. Biochem. J. 103, 514–& (1967).
Krebs, H. A. Gluconeogenesis and redox state. Hoppe-Seyler’s Z. Physiol. Chem. 351, 288 (1970).
Veech, R. L., Raijman, L. & KREBS, H. A. Equilibrium relations between the cytoplasmic adenine nucleotide system and nicotinamide–adenine nucleotide system in rat liver. Biochem. J. 117, 499–503 (1970).
Varoqui, H. & Erickson, J. D. Selective up-regulation of system a transporter mRNA in diabetic liver. Biochem. Biophys. Res. Commun. 290, 903–908 (2002).
Bröer, S. The SLC38 family of sodium-amino acid co-transporters. Pflugers Arch. 466, 155–172 (2014).
Day, S. E. et al. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat. Med. 13, 1382–1387 (2007).
Hurd, R. E. et al. Exchange-linked dissolution agents in dissolution-DNP (13)C metabolic imaging. Magn Reson Med 70, 936–942 (2013).
Chakravarty, K., Cassuto, H., Reshef, L. & Hanson, R. W. Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C. Crit. Rev. Biochem. Mol. Biol. 40, 129–154 (2005).
Krebs, H. A., Gascoyne, T. & Notton, B. M. Generation of extramitochondrial reducing power in gluconeogenesis. Biochem. J. 102, 275–282 (1967).
Rosen, F., Roberts, N. R. & Nichol, C. A. Glucocorticosteroids and transaminase activity. I. Increased activity of glutamicpyruvic transaminase in four conditions associated with gluconeogenesis. J. Biol. Chem. 234, 476–480 (1959).
Williamson, D. H., Lopes-Vieira, O. & Walker, B. Concentrations of free glucogenic amino acids in livers of rats subjected to various metabolic stresses. Biochem. J. 104, 497–502 (1967).
Wijekoon, E. P., Skinner, C., Brosnan, M. E. & Brosnan, J. T. Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Can. J. Physiol. Pharmacol. 82, 506–514 (2004).
Llorente, P., Marco, R. & Sols, A. Regulation of liver pyruvate kinase and the phosphoenolpyruvate crossroads. Eur. J. Biochem. 13, 45–54 (1970).
Stevens, H. C., Covey, T. R. & Dills, W. L. Inhibition of gluconeogenesis by 2,5-anhydro-D-mannitol in isolated rat hepatocytes. Biochim. Biophys. Acta 845, 502–506 (1985).
Kodama, H., Fujita, M. & Yamaguchi, I. Differential hypoglycemic effect of 2,5-anhydro-D-mannitol, a putative gluconeogenesis inhibitor, in genetically diabetic (db/db) and streptozotocin-induced diabetic mice. Jpn. J. Pharmacol. 66, 331–336 (1994).
Veech, R. L., Eggleston, L. V. & KREBS, H. A. The redox state of free nicotinamide–adenine dinucleotide phosphate in the cytoplasm of rat liver. Biochem. J. 115, 609–619 (1969).
Rogers, K. S., Higgins, E. S. & Kline, E. S. Experimental diabetes causes mitochondrial loss and cytoplasmic enrichment of pyridoxal phosphate and aspartate aminotransferase activity. Biochem. Med. Metab. Biol. 36, 91–97 (1986).
Masoro, E. J. & Porter, E. A comparison of fatty acid synthesis by liver and kidney. Proc. Soc. Exp. Biol. Med. 118, 1090–1095 (1965).
Palm, F., Ortsater, H., Hansell, P., Liss, P. & Carlsson, P. O. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model. Diabetes/Metabolism Research and Reviews 20, 452–459 (2004).
Shiota, M. & Printz, R. L. in Animal Models in Diabetes Research 103–123 (Humana Press, 2012). https://doi.org/10.1007/978-1-62703-068-7_8
Zhao, L., Mulkern, R. & Tseng, C. H. Zhao. Gradient-echo imaging considerations for hyperpolarized 129Xe MR. J Magn Reson B 113(2), 179–83 (1996).
Freeman, T. L., Ngo, H. Q. & Mailliard, M. E. Inhibition of system A amino acid transport and hepatocyte proliferation following partial hepatectomy in the rat. Hepatology 30, 437–444 (1999).
Hu, S. et al. Rapid sequential injections of hyperpolarized [1-¹³C]pyruvate in vivo using a sub-kelvin, multi-sample DNP polarizer. Magn Reson Imaging 31, 490–496 (2013).
Rosset, A., Spadola, L. & Ratib, O. OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging 17, 205–216 (2004).